We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

Find a share

Search for UK shares

Search

Market movers

United Kingdom
movers are constituents of the FTSE 350.
% GainersCompany
content
IC ViewLastChange
EVRAZ plc
EVR:LSE
142.70
GBX
+12.60
+9.68%
Bank of Georgia Holdings PLC
BGEO:LSE
2,067
GBX
+178.00
+9.42%
Nostrum Oil & Gas PLC
NOG:LSE
450.00
GBX
+30.00
+7.14%
Home Retail Group PLC
HOME:LSE
201.80
GBX
+10.10
+5.27%
Greggs PLC
GRG:LSE
737.50
GBX
+32.00
+4.54%
Polymetal International PLC
POLY:LSE
573.00
GBX
+23.00
+4.18%
Mitchells & Butlers PLC
MAB:LSE
374.00
GBX
+14.00
+3.89%
Afren PLC
AFR:LSE
49.39
GBX
+1.82
+3.83%
CLS Holdings PLC
CLI:LSE
1,525
GBX
+55.00
+3.74%
Ocado Group PLC
OCDO:LSE
394.70
GBX
+13.20
+3.46%
As of Dec 22 2014 16:35 GMT.

Companies news

Who bought who
Deal status
Deal value
Date
Repsol SAacquiredTalisman Energy IncAnnounced8.29bn15 Dec 2014
Koninklijke Philips Electronics NVacquiredVolcano CorpAnnounced947.58m17 Dec 2014
Alimentation Couche-Tard IncacquiredPantry IncAnnounced857.78m18 Dec 2014
Vocus Communications LtdacquiredAmcom Telecommunications LtdAnnounced515.48m17 Dec 2014
Northwest Bancshares IncacquiredLNB Bancorp IncAnnounced180.74m15 Dec 2014
1-5 of 9 results

Companies news

Financial Times articles may require a separate login and/or subscription to FT.com

Leniency expected from oil lenders
AstraZeneca wins ‘pay-for-delay’ ruling
Jamie Dimon has ‘no evidence of cancer’
Week in Review, December 6
Bonomi raises offer for Club Med

Featured company

Epistem Holdings PLCEHP:LSE

Epistem Holdings Plc (Epistem) is a United Kingdom-based biotechnology company focusing on epithelial stem cells in the areas of oncology, gastrointestinal disease, dermatology and ageing

© Thomson Reuters Click for restrictions.

All markets data located on Investors Chronicle is subject to the Investors Chronicle Terms & Conditions.

All content on Investors Chronicle is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Investors Chronicle and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Conditions.

Advertiser reports

Register today and get...

Register today and get...
Please note terms & conditions apply